Koninklijke Philips NV (RYLPF)

Royal Philips is a Dutch company that makes equipment and devices for hospitals and healthcare workers. It also sells health products to people at home. The company is big and global — it has factories and offices in dozens of countries. Most people have not heard of Philips, but if you have ever had a medical scan, used a blood-pressure monitor, or slept under its lighting, you have encountered the company’s products. Philips does not sell to consumers the way Apple does. Instead, it sells to hospitals, clinics, doctors, and healthcare systems. That is where the real money is.

What Philips makes

Philips makes several distinct kinds of products. The largest part of the business is healthcare technology. This includes diagnostic imaging equipment — machines that scan bodies and create the images doctors use to diagnose disease. CT scanners. MRI machines. Ultrasound equipment. X-ray systems. These are expensive, complex machines. A single system can cost hundreds of thousands of dollars. They need trained technicians to operate them and engineers to maintain them. Hospitals buy them because patients need them.

Beyond imaging, Philips makes patient-monitoring systems. These are devices that track heart rate, blood oxygen, blood pressure, and other vital signs. They sit at a patient’s bedside in an intensive care unit or operating room. They send data to a display that nurses and doctors watch. If something goes wrong — a heart rhythm becomes irregular, oxygen drops — the machine alerts the staff. These systems are essential in modern hospitals.

Philips also makes respiratory care equipment — ventilators and breathing-support devices that help patients who cannot breathe on their own. During the COVID pandemic, ventilators became household words. Philips is one of the few companies that makes them at scale.

The second part of the business is consumer health. This includes products people buy for their homes: electric toothbrushes, personal care shavers, air purifiers, humidifiers, and blood-pressure monitors. These are not high-cost items — a blood-pressure cuff costs tens of dollars, not tens of thousands. But they are useful, and millions of households buy them. The brand “Philips” on a health product at a drugstore carries the implicit promise that it is reliable and well-made. That brand trust matters.

The third part is lighting. Philips invented the electric lightbulb’s ancestor and has been in lighting for over a century. It makes industrial lighting for factories and offices, outdoor lighting for streets and sports fields, and consumer lighting for homes. Lighting is slowly becoming digital and connected — smart bulbs that you can control from your phone. This is not Philips’ main business anymore, but it is still a meaningful part of the company.

How the business actually works

A hospital wanting to buy an MRI scanner faces a handful of choices: Philips, Siemens, GE Healthcare, and a few others. The machines are expensive and complex. Choosing one is a big decision. The hospital considers the machine’s image quality, reliability, ease of use, and the vendor’s ability to service and upgrade it. Philips’ competitive advantage here is that it has been making imaging equipment for decades. Doctors and technicians trust the machines. The company also has service networks in most countries. If something breaks, a technician can usually be there within a day or two.

Once a hospital buys an MRI, it is not easy for them to switch. The staff has trained on it. The images are stored in formats tied to that system. The hospital has a service contract. Installing a new machine from a different vendor would be disruptive and expensive. This “switching cost” gives Philips pricing power. When the hospital needs upgrades or new features, it is more likely to buy from Philips than to rip out the old system and install a competitor’s machine.

The gross margins on these sales are high — typically 45% to 55%. The company makes the machine once and sells it many times. But the margins are not as high as software companies because making medical equipment is complicated and requires expertise, quality control, and regulatory compliance.

The recurring revenue machine

What makes Philips’ healthcare business valuable is not just equipment sales — it is the recurring revenue that comes after the sale. A hospital buys a scanner today. For the next 10 years, it needs service, maintenance, and parts from Philips. It needs software updates to meet new regulatory standards. It might buy add-on modules or upgrades. This recurring revenue is much more profitable than the initial sale because Philips does not have to manufacture another machine — it just provides services and software to the customer it already has.

Philips has increasingly framed its business this way. Instead of selling a machine for a fixed price, the company offers “as-a-service” contracts where the hospital pays a monthly or annual fee and Philips handles maintenance, updates, and support. The hospital pays less upfront but more over time. Philips gets predictable, recurring revenue. This is more like software business economics — high margins and revenue you can forecast.

Geographic dependence and market maturity

Philips sells most of its healthcare equipment in wealthy countries: the United States, Europe, and Japan. These countries have advanced healthcare systems and hospitals that can afford expensive equipment. Emerging markets represent growth potential, but many hospitals there cannot afford the price tags Philips commands.

The United States is Philips’ largest single market. American hospitals are wealthy and constantly upgrading technology. The company has a strong market position there. Europe is also significant — Philips is Dutch, and the company has deep roots throughout Western Europe. Asia-Pacific, particularly Australia and Japan, is established but smaller.

The consumer health business is more global and less concentrated. People everywhere use toothbrushes and care about blood-pressure monitors.

What could go wrong

Philips faces competition from Siemens, GE Healthcare, and regional players in specific markets. These are well-funded companies with strong track records and customer relationships. Competition on price is constant. Hospitals always want to pay less.

There is also regulatory risk. Healthcare equipment is heavily regulated — every new machine needs approval from regulators like the FDA in the United States. This is costly and slow. Regulators can also decide that Philips is pricing unfairly or that its equipment does not meet new safety standards. Changes in healthcare policy, reimbursement rates, or hospital spending can affect demand.

The consumer health business faces competition from brand names like Braun and Oral-B and from cheaper Chinese competitors who have moved into categories like air purifiers and toothbrushes.

Technological disruption is always a risk. If a startup invents a fundamentally better imaging technology or a cheaper alternative to expensive medical equipment, it could disrupt Philips’ business. This has not happened yet, but it remains a possibility.

How to research Philips

Read the 10-K filing (SEC CIK 0000313216). It breaks the company into segments and shows revenue and profitability for each. Watch the growth rate of recurring revenue as a percentage of total sales — this tells you if the company is successfully moving toward higher-margin service-based business. Look at orders and backlog for imaging equipment; these lead revenue and indicate future sales. For consumer health, watch growth rates and margins in categories like personal care and wellness. Examine gross margins by segment — healthcare should be in the 45–55% range, consumer health in the 35–45% range. Study the company’s geographic revenue mix and whether it is successfully growing in emerging markets. Monitor capital expenditure, since Philips must invest in research, manufacturing, and service networks to stay competitive. And keep an eye on regulatory news — any FDA warning or recall is important context. The healthcare sector is large and growing, which is good for Philips. But the company is mature and faces strong competition. Understanding whether it can grow faster than the market and maintain pricing power is key to assessing its investment case.